Showing results (21-30 of 240) with videos related to
Sort By:
Pageof 24
Journal of Psychoactive Drugs|July 28, 2018
Long-Term Heavy Recreational Cannabis Use and Serum Delta-9-Tetrahydrocannabinol Levels are not Associated with an Impaired Liver Function in Cannabis DependentsUdo Bonnet, Ali Canbay, Michael Specka, et al.Clinical Neuropharmacology|November 11, 2014
Use of disulfiram for alcohol relapse prevention in patients in opioid maintenance treatmentMichael Specka, Martin Heilmann, Bodo Lieb, et al.The Journal of Dermatology|December 23, 2020
Psychological burden of psoriatic patients in a German university hospital dermatology departmentWiebke Sondermann, Oliver Fiege, Andreas Körber, et al.Cannabis and Cannabinoid Research|October 27, 2021
Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney DysfunctionUdo Bonnet, Thorsten Borda, Norbert Scherbaum, et al.Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 2, 2020
[Scientific Rationale for the Directive on Opioid Substitution Treatment of the German Medical Association: A Summary]Wilfried Kunstmann, Michael Specka, Norbert Wodarz, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|November 8, 2022
Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping reviewUdo Bonnet, Michael Specka, Patrik Roser, et al.BMC Psychology|August 29, 2023
The impact of social connectedness on mental health in LGBTQ + identifying individuals during the COVID-19 pandemic in GermanyChristine Firk, Nicola Großheinrich, Norbert Scherbaum, et al.Deutsches Arzteblatt International|February 20, 2024
Phenibutan—an Illegal Food Supplement With Psychotropic Effects and Health RisksUdo Bonnet, Norbert Scherbaum, Andreas Schaper, et al.Fortschritte Der Neurologie-Psychiatrie|June 8, 2026
[Intravenous Subnarcotic Ketamine Infusions for Treatment-Resistant Depression: Historical Development, Comparison with Esketamine Nasalspray, and Prospects]Udo Bonnet, Norbert Scherbaum, Georg Juckel, et al.Pharmacopsychiatry|November 23, 2023
Augmentation of Electroconvulsive Therapy with Oral Caffeine: A Retrospective Analysis of 40 Patients with Major DepressionPeter Nyhuis, Dorothea Mücke, Michael Specka, et al.Pageof 24